UK approves the world’s first gene therapy for sickle cell and thalassemia

“The future of life-changing cures resides in CRISPR-based (gene-editing) technology,” said Dr Helen O'Neill (UCL EGA Institute for Women's Health) on the approval of the gene therapy that could offer relief to thousands of people in the UK suffering from genetic disorders.

Read: Mail Online, More: Telegraph (£), Los Angeles Times, Toronto Star, Time, Nature, CBC, The Pioneer